Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pedro Mondejar-López"'
Autor:
Pedro Mondejar-López, Laura Moreno-Galarraga, Cristina De Manuel, Enrique Blitz Castro, Maynor Bravo-Lopez, Silvia Gartner, Estela Pérez-Ruiz, Pilar Caro-Aguilera, Veronica Sanz Santiago, Alejandro López-Neyra, Maria Luna-Paredes, Miguel Garcia Gonzalez, Jordi Costa, Maria Cols-Roig, Isabel Delgado-Pecellín, Silvia Castillo-Corullón, Marta Ruiz de Valbuena, Patricia W. García-Marcos, Antonio Aguilar Fernandez, Carlos Martín, Mª Verisima Barajas Sanchez, Orlando Mesa Medina, Cati Bover-Bauza, Joan Figuerola Mulet, Belén García Avilés, Mª Jesus Rodriguez Saez, Carlos Garcia-Magan, Patricia Juarez Marruecos, Jose Ramon Gutierrez-Martinez, Isidoro Cortell-Aznar, David Gomez-Pastrana, M. Valle Velasco Miguelez, M. Isabel Barrio, Manuel Sanchez-Solis, Óscar Asensio de la Cruz, Maria Dolores Pastor-Vivero
Introduction Viral infections are associated with pulmonary exacerbations in children with Cystic Fibrosis (cwCF), but after 3 years of SARS-CoV-2 pandemic, whether cwCF are at higher risk of developing COVID-19 or its adverse consequences remains co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bc11da37d6a3ad60b23ca590e84c66f
https://doi.org/10.22541/au.168120188.86819508/v1
https://doi.org/10.22541/au.168120188.86819508/v1
Autor:
Senay Rueda-Nieto, Pedro Mondejar-Lopez, María-Pilar Mira-Escolano, Ana Cutillas-Tolín, Luis Alberto Maceda-Roldán, Julián Jesús Arense-Gonzalo, Joaquín A. Palomar-Rodríguez
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background Cystic fibrosis (CF) has a vast and heterogeneous mutational spectrum in Europe. This variability has also been described in Spain, and there are numerous studies linking CFTR variants with the symptoms of the disease. Most of the
Externí odkaz:
https://doaj.org/article/0cff6c0c626b44cba0eb64b18071ba8f
Autor:
Manuel, Muro, Pedro, Mondejar-López, María Rosa, Moya-Quiles, Gema, Salgado, María Dolores, Pastor-Vivero, Ruth, Lopez-Hernandez, Francisco, Boix, José Antonio, Campillo, Alfredo, Minguela, Ana, Garcia-Alonso, Manuel, Sánchez-Solís, María Rocío, Álvarez-López
Publikováno v:
Microbiology and immunology. 57(3)
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity pulmonary disease that affects both patients with cystic fibrosis (CF) and those with asthma. HLA-DRB1 alleles have previously been associated with ABPA-CF susceptibility; however,
Publikováno v:
Anales de Pediatría, Vol 90, Iss 4, Pp 251.e1-251.e10 (2019)
Resumen: El diagnóstico de fibrosis quística (FQ) a través del cribado neonatal (CN) está bien establecido en muchos países y brinda la oportunidad de un diagnóstico y tratamiento temprano antes del desarrollo de daño estructural pulmonar irre
Externí odkaz:
https://doaj.org/article/a9988150f03540c18860e7f7977fc9ce
Autor:
Silvia Gartner, Pedro Mondéjar-López, Óscar Asensio de la Cruz, María José Alonso, Marina Álvarez, Anselmo Andrés Martín, María Isabel Barrio Gómez de Agüero, María Jesús Cabero Pérez, Pilar Caro Aguilera, María Cols Roig, Isidoro Cortell Aznar-Pérez, Jordi Costa Colomer, Isabel Delgado Pecellín, Amparo Escribano Montaner, Joan Figuerola Mulet, Gloria García Hernández, Pilar Guayarte, David Gil Ortega, David Gómez Pastrana, Adelaida Lamas Ferreiro, José Luis Marín Soria, Carlos Martín de Vicente, Martín Navarro Merino, Concepción Oliva Hernández, Javier Pérez Frías, Estela Pérez Ruiz, Sandra Rovira Amigo, Antonio Salcedo Posadas, Manuel Sánchez-Solís, Josep Sirvent Gómez, Carlos Vázquez Cordero, José Ramón Villa Asensi
Publikováno v:
Anales de Pediatría (English Edition), Vol 90, Iss 4, Pp 251.e1-251.e10 (2019)
Newborn screening (NBS) for cystic fibrosis (CF) is well-established in many countries and provides the opportunity for an early diagnosis and treatment before the development of irreversible structural lung damage.In 1999, Catalonia, Castilla-León,
Externí odkaz:
https://doaj.org/article/8dd249170a644c38af89ff7e0f733184